Virksomheden fremlagde ligeledes resultater fra en række undersøgelser med andre vacciner, der indeholder andre serotyper af bluetongue- virus, samt publiceret information for at vise, hvordan vaccinen fungerer hos yngre får.
The company also presented results from a series of studies with other vaccines that contain other serotypes of the bluetongue virus, as well as published information to show how the vaccine will also work in younger sheep.